Literature DB >> 9213254

Effect of peripherally and centrally administered calcitonin on gallbladder emptying in dogs.

K Jonderko1, L Buéno.   

Abstract

The effect of calcitonin on meal-stimulated gallbladder emptying (GBE) was examined after intravenous (i.v.) and intracerebroventricular (i.c.v.) administration in six mongrel dogs. The gallbladder contraction was surveyed by means of real-time ultrasonography in conscious dogs. Calcitonin given i.v. elicited an immediate and strong inhibition of postprandial GBE-the integrated 0- to 120-min gallbladder response was 118.1 +/- 8.0%.h after placebo, whereas it was 91.8 +/- 2.1%.h, 59.4 +/- 17.9%.h (P < 0.001), and 14.2 +/- 20.5%.h (P < 0.001) after 3.6, 18.0, and 90.0 pmol.kg-1 calcitonin, respectively. After i.c.v. administration (1.8 and 18.0 pmol.kg-1), only the higher calcitonin dose exerted a moderate inhibitory effect on postprandial GBE. The calcitonin doses required to evoke a 50% inhibition of meal-stimulated GBE were 15- to 10-fold lower after i.v. than i.c.v. application. Peripherally given calcitonin brought about a dose-dependent increase in the interdigestive gallbladder volume-the linear regression of the relative gallbladder volume versus calcitonin dose was y = 11.60 [ln(dose + 1)] + 97.02 (r = 0.864, P < 0.001). Intravenous application of calcitonin did not affect caerulein-induced GBE. The results obtained imply that: (i) calcitonin exerts an inhibitory influence on meal-induced GBE and that this effect is more pronounced after i.v. than after i.c.v. administration, and (ii) peripherally given calcitonin does not inhibit caerulein-induced gallbladder contraction in the dog.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9213254     DOI: 10.1007/bf02934497

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  23 in total

1.  Effect of calcitonin on gastric emptying and on postprandial gastrin and insulin release in patients with type I gastric ulcer.

Authors:  G Jonderko; K Jonderko; T Gołab
Journal:  Neth J Med       Date:  1990-08       Impact factor: 1.422

2.  Real-time ultrasonography as a noninvasive tool for the examination of canine gallbladder emptying: a validation study.

Authors:  K Jonderko; J P Ferré; L Buéno
Journal:  J Pharmacol Toxicol Methods       Date:  1992-04       Impact factor: 1.950

3.  Immunoextracted calcitonin in human gastric secretion.

Authors:  E Bucht; O Wisén; B Granberg; H E Sjöberg
Journal:  Peptides       Date:  1988 Mar-Apr       Impact factor: 3.750

4.  Effect of calcitonin on gastric emptying and on serum insulin and gastrin concentrations after ingestion of a mixed solid-liquid meal in humans.

Authors:  K Jonderko; G Jonderko; T Gołab
Journal:  J Clin Gastroenterol       Date:  1990-02       Impact factor: 3.062

5.  Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation.

Authors:  E Passaro; H Debas; W Oldendorf; T Yamada
Journal:  Brain Res       Date:  1982-06-10       Impact factor: 3.252

6.  Effect of calcitonin on gastric and pancreatic secretion and peptic ulcer formation in cats.

Authors:  S J Konturek; T Radecki; D Konturek; T Dimitrescu
Journal:  Am J Dig Dis       Date:  1974-03

7.  Calcitonin in human gastric mucosa and carcinoma.

Authors:  H Ito; J Hata; H Yokozaki; E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Effect of calcitonin and calcitonin gene-related peptide on pancreatic functions in man.

Authors:  C Beglinger; E Koehler; W Born; J A Fischer; U Keller; L E Hanssen; K Gyr
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

9.  Calcitonin and CGRP inhibit gastrointestinal transit via distinct neuronal pathways.

Authors:  H Jürgen Lenz
Journal:  Am J Physiol       Date:  1988-06

10.  Effects of cisapride on gallbladder emptying and pancreatic polypeptide and cholecystokinin release in humans.

Authors:  T Meguro; T Shimosegawa; Y Kikuchi; M Koizumi; T Toyota
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.